{
    "organizations": [],
    "uuid": "68b14bd71faeb4d3d905ab294de96f0dba81e500",
    "author": "",
    "url": "https://www.reuters.com/article/brief-astrazeneca-announces-renewed-us-r/brief-astrazeneca-announces-renewed-u-s-recommendation-availability-of-flumist-quadrivalent-vaccine-idUSFWN1QB10R",
    "ord_in_thread": 0,
    "title": "BRIEF-Astrazeneca Announces Renewed U.S. Recommendation, Availability Of Flumist Quadrivalent Vaccine",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "February 21, 2018 / 8:42 PM / Updated 15 minutes ago BRIEF-Astrazeneca Announces Renewed U.S. Recommendation, Availability Of Flumist Quadrivalent Vaccine Reuters Staff Feb 21 (Reuters) - AstraZeneca PLC: * ASTRAZENECA ANNOUNCES RENEWED RECOMMENDATION AND AVAILABILITY OF FLUMIST QUADRIVALENT VACCINE IN THE US * ASTRAZENECA - RESULTS DEMONSTRATED NEW 2017-2018 H1N1 LAIV POST-PANDEMIC STRAIN PERFORMED BETTER THAN 2015-2016 H1N1 LAIV POST-PANDEMIC STRAIN​ * ASTRAZENECA - CDC‘S ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES VOTED IN FAVOR OF RENEWED RECOMMENDATION FOR FLUMIST QUADRIVALENT USE IN U.S. 2018-2019 SEASON Source text for Eikon: Further company coverage:",
    "published": "2018-02-21T22:41:00.000+02:00",
    "crawled": "2018-02-21T23:06:15.050+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "february",
        "pm",
        "updated",
        "minute",
        "ago",
        "announces",
        "renewed",
        "recommendation",
        "availability",
        "flumist",
        "quadrivalent",
        "vaccine",
        "reuters",
        "staff",
        "feb",
        "reuters",
        "astrazeneca",
        "plc",
        "astrazeneca",
        "announces",
        "renewed",
        "recommendation",
        "availability",
        "flumist",
        "quadrivalent",
        "vaccine",
        "u",
        "astrazeneca",
        "result",
        "demonstrated",
        "new",
        "h1n1",
        "laiv",
        "strain",
        "performed",
        "better",
        "h1n1",
        "laiv",
        "astrazeneca",
        "cdc",
        "advisory",
        "committee",
        "immunization",
        "practice",
        "voted",
        "favor",
        "renewed",
        "recommendation",
        "flumist",
        "quadrivalent",
        "use",
        "season",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}